Assessment of antioxidant, hypoglycemic and hypolypidemic activities of the herbal extract of hill-growing saltwort (Salsola collina)

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. The development of safe and effective natural antioxidant drugs is an important task in the prevention and treatment of cardiovascular diseases, which are a serious public health problem.

Work Objective is a study of the antioxidant, hypoglycemic and hypolipidemic activities of the herbal extract of hill-growing saltwort (Salsola collina) in comparison with the effect of a standard antioxidant agent.

Material and methods. The object of the study was a "Hepatosol" biologically active food supplement based on a dry concentrated aqueous extract of the Salsola collina herb in capsules.

The patients under observation were matched groups of obese women and men of comparable age with risk factors for cardiovascular diseases. During the study, tolerability and possible adverse events were recorded and vital signs were monitored. The results of a biochemical blood test, lipid profile, oxidative stress and body composition analysis of patients were also evaluated and interpreted.

Results. It has been found out that the parameters of the lipid profile and antioxidant status in patients with obesity and a risk of cardiovascular complications taking the herbal extract of hill-growing saltwort for 3 months returned to normal. A hypoglycemic positive effect of the herbal extract of hill-growing saltwort on reducing the body weight of patients has been recorded. The safety and good tolerability of the study drug have been confirmed.

Conclusions. The results of studies show that a biologically active food supplement "Hepatosol" based on the extract of the Salsola collina herb has antioxidant, hypoglycemic and hypolipidemic activities. Due to these properties, the drugs based on a dry concentrated aqueous extract of the Salsola collina herb are favorable for diet therapy of patients with diabetes mellitus, for weight loss and use in the prevention and complex therapy of cardiovascular diseases.

Full Text

Restricted Access

About the authors

N. V. Korotchenko

Tomsk Regional Center for the Prevention and Control of AIDS and Other Infectious Diseases

Email: infobiolit@yandex.ru
ORCID iD: 0009-0000-0978-1999

Infectious Disease Doctor

Russian Federation, 5a Smirnova st., Tomsk, 634059

V. P. Sergun

"Biolit" LLC

Email: infobiolit@yandex.ru
ORCID iD: 0009-0003-6368-9992

Ph. D. (Chem.), Director

Russian Federation, 4 bilding 3, Akademichesky Ave, Tomsk, 634055

A. A. Ivanov

"Biolit" LLC

Author for correspondence.
Email: infobiolit@yandex.ru
ORCID iD: 0009-0004-4321-388X

Ph. D. (Chem.), Head of Research Department

Russian Federation, 4 bilding 3, Akademichesky Ave, Tomsk, 634055

V. N. Burkova

"Biolit" LLC

Email: infobiolit@yandex.ru
ORCID iD: 0009-0003-4253-4764

Dr. Sc. (Chem.), Director of Science and Innovation

Russian Federation, 4 bilding 3, Akademichesky Ave, Tomsk, 634055

Yu. G. Samoylova

Siberian State Medical University

Email: infobiolit@yandex.ru
ORCID iD: 0000-0002-2667-4842

Dr. Sc. (Med.), Professor, Department of Endocrinology and Diabetology

Russian Federation, Main Building 2, Moskovsky trakt, 634050, Tomsk

References

  1. Matuz-Mares D., Riveros-Rosas H., Vilchis-Landeros M. M. et al. Glutathione Participation in the Prevention of Cardiovascular Diseases. Antioxidants. 2021; 10(8): 1220.
  2. Yan Q., Liu S., Sun Y. et al. Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease. J. Transl. Med. 2023; 21: 519.
  3. Nojiri S., Daida H., Inaba Y. Antioxidants and cardiovascular disease: Still a topic of interest. Environ. Health Prev. Med. 2004; 9: 200–213.
  4. Dianita R., Jantan I., Jalil J. et al. Effects of Labisiapumila var alataextracts on the lipid profile, serumantioxidantstatus and abdominal aorta of high-cholesteroldiet rats. Phytomedicine. 2016; 23(8): 810–817.
  5. Saratikov A. S., Vengerovskij A. I., Chuchalin V. S., Burkova V. N., Ivanov A. A., Sergun V. P., Sotnikova L. S. Soljanka holmovaja v sovremennyh preparatah dlja personalizirovannoj mediciny. Izdanie 2-e, dopolnennoe i pererabotannoe. Tomsk. 2019. 224 s.
  6. Korotchenko N. V., Sotnikova L. S., Burkova V. N. i dr. Optimizacii sostojanija reguljatornyh sistem zhizneobespechenija organizma i normalizacii sostojanija gomeostaza s pomoshh'ju rastitel'nyh sredstv na osnove soljanki holmovoj. Vestnik Bashkirskogo gosudarstvennogo medicinskogo universiteta. 2021; № 3: 57–64.
  7. Lunjak N. K. Metabolicheskaja terapija preparatami soljanki holmovoj. M. 1999. 49 s.
  8. Santacroce G., Gentile A., Soriano S. et al. Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease. Front. Med. March 2023; 10: 1124275.
  9. Pizzorno J. Glutathione! Integr Med (Encinitas). 2014; 13: 8–12.
  10. Glutathione, reduced (GSH). Monograph. Altern Med Rev. 2001; 6(6): 601–607.
  11. Richie J. P. Jr., Nichenametla S., Neidig W. et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015; 54(2): 251–263.
  12. Orlova S. V., Nikitina E. A. Glutation dlja zashhity pecheni. Terapija Jevalar. 2022; 1(6): 12–14.
  13. Jakovleva G. E. Fermenty v klinicheskoj biohimii. Novosibirsk. 2005. 44 s.
  14. Nazarenko G. I., Kishkun A. Klinicheskaja ocenka rezul'tatov laboratornyh issledovanij. M. 2000. 544 s.
  15. Chopra M., Thurnham D. I. Antioxidants and lipoprotein metabolism. Proceedings of the Nutrition Society. 1999; 58(3): 663–671.
  16. Danilova L. G. Lipidnyj obmen i antioksidanty. Mezhdunarodnyj zhurnal prikladnyh i fundamental'nyh issledovanij. 2013; № 10-1: S. 92–92.
  17. Ward N. C., Watts G. F., Eckel R. H. Statin Toxicity. Circ Res. 2019; 124(2): 328–350.
  18. Djadyk A. I., Kugler T. E., Suliman Ju. V. i dr. Pobochnye jeffekty statinov: mehanizmy razvitija, diagnostika, profilaktika i lechenie. Arhiv# Vnutrennej Mediciny. 2018; 8(4):2 66–76.
  19. Xiang F., Shuanglun X., Jingfeng W. et al. Association of serum 8-hydroxy-2′-deoxyguanosine levels with the presence and severity of coronary artery disease. Coronary Artery Disease. 2011; 22(4): 223–227.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies